MedTrace Logo

IDUS in CBD Stone Recurrence High Risk Patients

NCT06265311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 248

Last updated 2026-04-20

No results posted yet for this study

Summary

This study is designed to observed CBD stones cases with high recurrence risks applying IDUS or not during ERCP.

Patients with CBD stone high recurrence risks were enrolled in this study, and prospectively randomized into IUDS group and control group during lithotomy.

Operation time, radiation time, hospitalization cost, retain of nasobiliary tube, deployment of stent were recorded.

Symptoms and conditions after ERCP were also followed up including blood amylase, routine blood test, abdominal pain, post-ERCP pancreatitis, resection of gallbladder, recurrence of CBD stone and onset of cholangitis.

Conditions

  • Choledocholithiasis
  • Cholangiopancreatography, Endoscopic Retrograde
  • Ultrasonography

Interventions

PROCEDURE

IDUS examination

for patients with high risks of bile duct stones recurrence using IDUS during ERCP

Sponsors & Collaborators

  • Shanghai Municipal Hospital of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Hang Zhao, PhD · Shanghai Municipal Traditional Chinese Medicine Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-02
Primary Completion
2024-01-31
Completion
2026-04-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06265311 on ClinicalTrials.gov